{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:02:28Z","timestamp":1755993748519,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"DOI":"10.7759\/cureus.90772","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T01:27:57Z","timestamp":1755912477000},"source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Analysis of the Uptake and Timing of Risk-Reducing Salpingo-Oophorectomy in Women With BRCA1\/2 Pathogenic Variants"],"prefix":"10.7759","author":[{"given":"Yuri","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahoko","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonori","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.531790","article-title":"Pathology of hereditary breast and ovarian cancer","volume":"10","author":"Hodgson A","year":"2020","unstructured":"Hodgson A, Turashvili G. Pathology of hereditary breast and ovarian cancer. Front Oncol. 2020, 10:531790. 10.3389\/fonc.2020.531790","journal-title":"Front Oncol"},{"key":"ref2","article-title":"BRCA1 and BRCA2-associated hereditary breast and ovarian cancer","author":"Petrucelli N","year":"2025","unstructured":"Petrucelli N, Daly MB, Pal T. BRCA1 and BRCA2-associated hereditary breast and ovarian cancer. GeneReviews\u00ae. University of Washington, Seattle, Seattle, WA; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012464.pub2","article-title":"Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations","volume":"8","author":"Eleje GU","year":"2018","unstructured":"Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Database Syst Rev. 2018, 8:CD012464. 10.1002\/14651858.CD012464.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly MB","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al.. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:77-102. 10.6004\/jnccn.2021.0001","journal-title":"J Natl Compr Canc Netw"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.02.019","article-title":"Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis","volume":"48","author":"Wang Y","year":"2022","unstructured":"Wang Y, Song Z, Zhang S, Wang X, Li P. Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis. Eur J Surg Oncol. 2022, 48:1209-16. 10.1016\/j.ejso.2022.02.019","journal-title":"Eur J Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.02.008","article-title":"Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology\/Gynecologic Oncology Group study","volume":"145","author":"Mai PL","year":"2017","unstructured":"Mai PL, Piedmonte M, Han PK, et al.. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology\/Gynecologic Oncology Group study. Gynecol Oncol. 2017, 145:122-9. 10.1016\/j.ygyno.2017.02.008","journal-title":"Gynecol Oncol"},{"key":"ref7","unstructured":"Japan Society of Gynecologic Oncology. Concept of insurance reimbursement for hereditary breast and ovarian cancer syndrome in obstetrics and gynecology [source in Japanese]. (2021). Accessed. August 20, 2025: https:\/\/jsgo.or.jp\/opinion\/05.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell CB","year":"2011","unstructured":"Powell CB, Chen LM, McLennan J, et al.. Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol. Int J Gynecol Cancer. 2011, 21:846-51. 10.1097\/IGC.0b013e31821bc7e3","journal-title":"Int J Gynecol Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros F","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y, et al.. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006, 30:230-6. 10.1097\/01.pas.0000180854.28831.77","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01456-4","article-title":"Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan","volume":"24","author":"Nomura H","year":"2019","unstructured":"Nomura H, Sekine M, Yokoyama S, Arai M, Enomoto T, Takeshima N, Nakamura S. Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan. Int J Clin Oncol. 2019, 24:1105-10. 10.1007\/s10147-019-01456-4","journal-title":"Int J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-025-01326-0","article-title":"The impact of public insurance on RRSO for HBOC in Japan: a nationwide data study","volume":"70","author":"Matsumoto M","year":"2025","unstructured":"Matsumoto M, Den H, Miura S, et al.. The impact of public insurance on RRSO for HBOC in Japan: a nationwide data study. J Hum Genet. 2025, 70:421-6. 10.1038\/s10038-025-01326-0","journal-title":"J Hum Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-017-0355-1","article-title":"Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan","volume":"63","author":"Arai M","year":"2018","unstructured":"Arai M, Yokoyama S, Watanabe C, et al.. Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan. J Hum Genet. 2018, 63:447-57. 10.1038\/s10038-017-0355-1","journal-title":"J Hum Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.06.070","article-title":"Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations","volume":"225","author":"Smith MJ","year":"2021","unstructured":"Smith MJ, Gerber D, Olsen A, et al.. Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations. Am J Obstet Gynecol. 2021, 225:508.e1-508.e10. 10.1016\/j.ajog.2021.06.070","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek SM","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, et al.. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010, 304:967-75. 10.1001\/jama.2010.1237","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff ND","year":"2008","unstructured":"Kauff ND, Domchek SM, Friebel TM, et al.. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol. 2008, 26:1331-7. 10.1200\/JCO.2007.13.9626","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/392725-retrospective-analysis-of-the-uptake-and-timing-of-risk-reducing-salpingo-oophorectomy-in-women-with-brca12-pathogenic-variants","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T01:27:59Z","timestamp":1755912479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/392725-retrospective-analysis-of-the-uptake-and-timing-of-risk-reducing-salpingo-oophorectomy-in-women-with-brca12-pathogenic-variants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.90772","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}